| Version 2 (modified by luciano.ramalho, 4 years ago) |
|---|
Field 13. Intervention(s)
WHO description
Enter the specific name of the intervention(s) and the comparator/control(s) being studied. Use the International Non-Proprietary Name if possible (not brand/trade names). For an unregistered drug, the generic name, chemical name, or company serial number is acceptable. If the intervention consists of several separate treatments, list them all in one line separated by commas (e.g., "low-fat diet, exercise").
Schema
Validation
Labels
EN:
PT:
ES:
Sample Values
- sample 1
- sample 2
- sample 3
Discussion
Notes taken by LR 2009-08-06:
- schema
- repeating, two sub-fields: intervention_type: string, editable, choices as above; intervention_description: string, editable
- choices
- intervention_type: from "tipo de intervenção" from Plataforma Brasil, including "other"
- intervention_type
- drug
- intervention_description
- uso
- intervention_description_administration_route
- (ask Claudio Nishizawa)
- intervention_description_pharmaceutical_form
- (ask Claudio Nishizawa)
- intervention_code_dci
- (ask Claudio Nishizawa, content only in English and Spanish)
- intervention_code_devices
- (ask Claudio Nishizawa)
- control_intervention_type
- check ANZCTR (ask Laguardia)
- control_intervention_description
- check ANZCTR (ask Laguardia)
- custom_intervention_code_dcb
- (ask Claudio Nishizawa)
- custom_intervention_code_homeopatia
- (ask Claudio Nishizawa)
- custom_intervention_code_tabela_fitoterapicos
- (ask Ricardo Gamarski)
(use this area to post further suggestions)
Part of: TrialRegistrationDataSet
